Many American healthtech companies would have more success in emerging markets
06-Apr-17, MedTech Intelligence
Global healthcare spending is roughly USD7 trillion, according to Matthew Hein, International Trade Specialist for the U.S. Department of Commerce. Considering the market outside of the United States is about 25% larger, companies may have more success pursuing product approval in emerging markets - beyond China, India and Brazil - because the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggests Hein.
%20MedTech%20Intelligence.jpg "Many American healthtech companies would have more success in emerging markets (c) MedTech Intelligence")
Image: MedTech Intelligence
Watch video here.